Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

bioAffinity Technologies (BIAF) Leases (2023 - 2025)

bioAffinity Technologies (BIAF) has disclosed Leases for 3 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Leases fell 8.47% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, down 8.47% year-over-year, with the annual reading at $1.2 million for FY2025, 8.47% down from the prior year.
  • Leases for Q4 2025 was $1.2 million at bioAffinity Technologies, up from $565030.0 in the prior quarter.
  • The five-year high for Leases was $1.3 million in Q4 2023, with the low at $565030.0 in Q2 2025.
  • Average Leases over 3 years is $1.1 million, with a median of $1.3 million recorded in 2023.
  • The sharpest move saw Leases increased 2.54% in 2024, then plummeted 56.34% in 2025.
  • Over 3 years, Leases stood at $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then dropped by 8.47% to $1.2 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $1.2 million, $565030.0, and $565030.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.